Towards a dietary prevention of hereditary breast cancer

Cancer Causes and Control

Volumn 16, Issue 2, 2005, Pages 125-138

  Kotsopoulos, Joanne ^a,b   Narod, Steven A ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

BRCA1; BRCA2; Chemoprevention; Diindolylmethane; DNA damage; DNA repair; EGCG; Estrogen; Green tea; Hereditary breast cancer; Lycopene; Oxidative stress; Selenium

Indexed keywords

16ALPHA HYDROXYESTRONE; 2 HYDROXYESTRONE; ALPHA TOCOPHEROL; ANTIOXIDANT; BRCA1 PROTEIN; CAROTENOID; DIINDOLYLMETHANE; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOLE DERIVATIVE; LYCOPENE; POLYPHENOL DERIVATIVE; SELENIUM; TRACE ELEMENT; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER PREVENTION; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CLINICAL TRIAL; COLON CANCER; DAIRY PRODUCT; DIET; DISEASE CARRIER; DNA DAMAGE; DNA REPAIR; DNA STRUCTURE; DNA SYNTHESIS; EXCISION REPAIR; FAMILIAL CANCER; FRUIT; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; LUNG CANCER; NONHUMAN; POULTRY; PRIORITY JOURNAL; PROSTATE CANCER; SEA FOOD; SKIN CANCER; TEA; VEGETABLE;

BREAST NEOPLASMS; DIET; FEMALE; FOOD HABITS; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION; NUTRITION PHYSIOLOGY; PENETRANCE; RISK FACTORS;

EID: 18844372248     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10552-004-2593-8     Document Type: Article

References (240)

1. D Easton J. Peto 1990 The contribution of inherited predisposition to cancer incidence Cancer Surv. 9 3 395 416
2. EB Claus N Risch WD Thompson 1991 Genetic analysis of breast cancer in the cancer and steroid hormone study Am J Hum Genet. 48 2 232 242
3. D Ford 1998 Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. the breast cancer linkage consortium Am J Hum Genet. 62 3 676 689
4. DF Easton D Ford DT Bishop 1995 Breast and ovarian cancer incidence in BRCA1-mutation carriers. breast cancer linkage consortium Am J Hum Genet. 56 1 265 271
5. ME Robson 2002 Clinical considerations in the management of individuals at risk for hereditary breast and ovarian cancer Cancer Control. 9 6 457 465
6. Cancer risks in BRCA2 mutation carriers. 1999 The Breast Cancer Linkage Consortium J Natl Cancer Inst. 91 15 1310 1316
7. D Thompson DF Easton 2002 Cancer incidence in BRCA1 mutation carriers J Natl Cancer Inst. 94 18 1358 1365
8. D Ford 1994 Risks of cancer in BRCA1-mutation carriers Breast Cancer Linkage Consortium. Lancet. 343 8899 692 695
9. DF Easton 1997 Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13 Am J Hum Genet 61 1 120 128
10. JP Struewing 1997 The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews N Engl J Med 336 20 1401 1408
11. JM Satagopan 2001 The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations Cancer Epidemiol Biomarkers Prev. 10 5 467 473
12. A Antoniou 2003 Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies Am J Hum Genet 72 5 1117 1130
13. S Narod 1993 Increasing incidence of breast cancer in family with BRCA1 mutation Lancet. 341 8852 1101 1102
14. SA Narod 2002 Modifiers of risk of hereditary breast and ovarian cancer Nat Rev Cancer. 2 2 113 123
15. SA Narod 2001 Hormonal prevention of hereditary breast cancer Ann NY Acad Sci. 952 36 43
16. MC King JH Marks JB Mandell 2003 Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2 Science. 302 5645 643 646
17. SA Gayther 1995 Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation Nat Genet. 11 4 428 433
18. SA Gayther 1997 Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene Nat Genet. 15 1 103 105
19. D Thompson D Easton 2001 Variation in cancer risks, by mutation position, in BRCA2 mutation carriers Am J Hum Genet. 68 2 410 419
20. TR Rebbeck 1999 Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat Am J Hum Genet. 64 5 1371 1377
21. Rebbeck TR, et al. Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history. Cancer Res. 61(14): 5420-5424
22. WW Wang 2001 A single nucleotide polymorphism in the 5′ untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers Cancer Epidemiol Biomarkers Prev. 10 9 955 960
23. E Levy-Lahad 2001 A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers Proc Natl Acad Sci USA. 98 6 3232 3236
24. SA Narod 1995 Risk modifiers in carriers of BRCA1 mutations Int J Cancer. 64 6 394 398
25. TR Rebbeck 1999 Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers J Natl Cancer Inst. 91 17 1475 1479
26. Eisen A, et al. (2000) Reduction in breast cancer risk following bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers. Am J Hum Genet. 67(58)
27. Jernstrom H, et al. (2004) Breast-feeding and the risk of cancer in BRCA1 and BRCA2 carriers. J Natl Cancer Inst
28. G Ursin 1997 Does oral contraceptive use increase the risk of breast cancer in women with BRCA1/BRCA2 mutations more than in other women? Cancer Res 57 17 3678 3681
29. LC Hartmann 2001 Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst. 93 21 1633 1637
30. KA Metcalfe 2002 Prophylactic bilateral mastectomy: patterns of practice Cancer. 95 2 236 242
31. R Scully DM Livingston 2000 In search of the tumour-suppressor functions of BRCA1 and BRCA2 Nature. 408 6811 429 432
32. A Tutt A Ashworth 2002 The relationship between the roles of BRCA genes in DNA repair and cancer predisposition Trends Mol Med. 8 12 571 576
33. AR Venkitaraman 2002 Cancer susceptibility and the functions of BRCA1 and BRCA2 Cell. 108 2 171 182
34. AR Hartman JM Ford 2002 BRCA1 induces DNA damage recognition factors and enhances nucleotide excision repair Nat Genet. 32 1 180 184
35. R Takimoto 2002 BRCA1 transcriptionally regulates damaged DNA binding protein (DDB2) in the DNA repair response following UV-irradiation Cancer Biol Ther. 1 2 177 186
36. F Le Page 2000 BRCA1 and BRCA2 are necessary for the transcription- coupled repair of the oxidative 8-oxoguanine lesion in human cells Cancer Res. 60 19 5548 5552
37. AA Davies 2001 Role of BRCA2 in control of the RAD51 recombination and DNA repair protein Mol Cell. 7 2 273 282
38. R Scully 1997 Association of BRCA1 with Rad51 in mitotic and meiotic cells Cell. 88 2 265 275
39. PL Chen 1998 The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment Proc Natl Acad Sci USA. 95 9 5287 5292
40. R Mizuta 1997 RAB22 and RAB163/mouse BRCA2: proteins that specifically interact with the RAD51 protein Proc Natl Acad Sci USA. 94 13 6927 6932
41. DS Yu 2003 Dynamic control of Rad51 recombinase by self-association and interaction with BRCA2 Mol Cell. 12 4 1029 1041
42. M Lomonosov 2003 Stabilization of stalled DNA replication forks by the BRCA2 breast cancer susceptibility protein Genes Dev. 17 24 3017 3022
43. ME Moynahan AJ Pierce M Jasin 2001 BRCA2 is required for homology-directed repair of chromosomal breaks Mol Cell. 7 2 263 272
44. ME Moynahan 1999 Brca1 controls homology-directed DNA repair Mol Cell. 4 4 511 518
45. D Marsh R Zori 2002 Genetic insights into familial cancers - update and recent discoveries Cancer Lett. 181 2 125 164
46. JH Hoeijmakers 2001 Genome maintenance mechanisms for preventing cancer Nature. 411 6835 366 374
47. LH Thompson D Schild 2002 Recombinational DNA repair and human disease Mutat Res. 509 1-2 49 78
48. M. Christmann 2003 Mechanisms of human DNA repair: an update Toxicology. 193 1-2 3 34
49. AD Auerbach M Buchwald H Joenje CR Scriver 2001 The Metabolic and Molecualr Basis of Inherited Disease McGraw-Hill New York
50. CS Djuzenova 1999 Identification of ataxia telangiectasia heterozygotes, a cancer-prone population, using the single-cell gel electrophoresis (Comet) assay Lab Invest. 79 6 699 705
51. F Meyn 1999 Ataxia telangiectasia R Kurzock M Talpaz Molecular Biology in Cancer Medicine Martin Dunitz London 549 568
52. RJ Scott 2004 DNA double strand break repair and its association with inherited predispositions to breast cancer Hereditary Cancer Clin Pract. 2 1 37 43
53. M Berwick P Vineis 2000 Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review J Natl Cancer Inst. 92 11 874 897
54. K Hemminki WG Thilly 2004 Implications of results of molecular epidemiology on DNA adducts, their repair and mutations of human cancer P Buffler Mechanisms of Carcinogenesis: Contributions of Molecular Epidemiology IARC Scientific Publications Lyon, France
55. H Norppa 2004 Cytogenetic biomarkers P Buffer Mechanisms of Carcinogenesis: Contributions of Molecular Epidemiology IARC Scientific Publications Lycon 179 205
56. L Hagmar 2004 Epidemiological evidence of cytogenetic biomarkers as potential surrogate end-points for cancer P Buffer Mechanisms of Carcinogenesis: Contributions of Molecular Epidemiology IARC Scientific Publications Lyon 207 215
57. N Rajeswari 2000 Risk assessment in first degree female relatives of breast cancer patients using the alkaline Comet assay Carcinogenesis. 21 4 557 561
58. J Cadet 1997 Oxidative damage to DNA: formation, measurement, and biological significance Rev Physiol Biochem Pharmacol. 131 1 87
59. BN Ames MK Shigenaga TM Hagen 1993 Oxidants, antioxidants, and the degenerative diseases of aging Proc Natl Acad Sci USA. 90 17 7915 7922
60. L Castro BA Freeman 2001 Reactive oxygen species in human health and disease Nutrition. 17 2 161, 163 165
61. BN Ames LS Gold WC Willett 1995 The causes and prevention of cancer Proc Natl Acad Sci USA. 92 12 5258 5265
62. J Pincemail 1995 Free radicals and antioxidants in human disease AE Favier Analysis of Free Radicals in Biological Systems Birkhauser Verlag Basel, Switzerland 83 98
63. B Halliwell 1994 Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet. 344 8924 721 724
64. CB Ambrosone 2000 Oxidants and antioxidants in breast cancer Antioxid Redox Signal. 2 4 903 917
65. BN Ames MK Shigenaga LS Gold 1993 DNA lesions, inducible DNA repair, and cell division: three key factors in mutagenesis and carcinogenesis Environ Health Perspect. 101 (Suppl 5 35 44
66. F Le Page A Gentil A Sarasin 1999 Repair and mutagenesis survey of 8-hydroxyguanine in bacteria and human cells Biochimie. 81 1-2 147 153
67. S Shibutani M Takeshita AP Grollman 1991 Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG Nature. 349 6308 431 434
68. P Vineis F Perera 2000 DNA adducts as markers of exposure to carcinogens and risk of cancer Int J Cancer. 88 3 325 328
69. S Bonassi M Neri R Puntoni 2001 Validation of biomarkers as early predictors of disease Mutat Res. 480 -481 349 358
70. H Kasai 1997 Analysis of a form of oxidative DNA damage, 8-hydroxy-2′-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis Mutat Res. 387 3 147 163
71. A Rothfuss 2000 Induced micronucleus frequencies in peripheral lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families Cancer Res. 60 2 390 394
72. K Trenz 2002 Mutagen sensitivity of peripheral blood from women carrying a BRCA1 or BRCA2 mutation Mutat Res. 500 1-2 89 96
73. TA Buchholz 2002 Evidence of haplotype insufficiency in human cells containing a germline mutation in BRCA1 or BRCA2 Int J Cancer. 97 5 557 561
74. G Block B Patterson A Subar 1992 Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence Nutr Cancer. 18 1 1 29
75. W.C.R.F.a.A.I.f.C. Research, ed. (1997) Food, Nutrition and the Prevention of Cancer: A Global Perspective. Washington DC: American Institute for Cancer Research
76. WC Willett 1994 Diet and health: what should we eat? Science. 264 5158 532 537
77. WC Willett 1995 Diet, nutrition, and avoidable cancer Environ Health Perspect. 103 8 165 170
78. PL Welcsh MC King 2001 BRCA1 and BRCA2 and the genetics of breast and ovarian cancer Hum Mol Genet. 10 7 705 713
79. AN Monteiro 2003 BRCA1: the enigma of tissue-specific tumor development Trends Genet. 19 6 312 315
80. TJ Key 1999 Serum oestradiol and breast cancer risk Endocr Relat Cancer. 6 2 175 180
81. R Scully 2000 Role of BRCA gene dysfunction in breast and ovarian cancer predisposition Breast Cancer Res. 2 5 324 330
82. N.R. Board C.F. a.N 1989 Recommended Dietary Allowances National Academy Press Washington DC
83. Klein EA (2004) Selenium: epidemiology and basic science. J Urol 171(2 Pt 2): S50-S53; discussion S53
84. B Corvilain 1993 Selenium and the thyroid: how the relationship was established. Am J Clin Nutr 57 2 244S 248S
85. RS Bedwal 1993 Selenium - its biological perspectives Med Hypotheses. 41 2 150 159
86. JA Pennington SA Schoen 1996 Contributions of food groups to estimated intakes of nutritional elements: results from the FDA total diet studies, 1982-1991 Int J Vitam Nutr Res. 66 4 342 349
87. JA Pennington BE Young 1991 Total diet study nutritional elements, 1982-1989 J Am Diet Assoc. 91 2 179 183
88. JG Combs LC Clark 1997 Selenium and cancer H Garewal Antioxidants and Disease Prevention CRC Press New York
89. K El-Bayoumy 1991 The role of selenium in cancer prevention VT De Vita S Hellman SS Rosenberg Practice of Oncology Lippincott Philadelphia
90. GF Combs Jr WP Gray 1998 Chemopreventive agents: selenium Pharmacol Ther. 79 3 179 192
91. C Ip D Medina 1987 Current concept of selenium and mammary tumorigenesis D Medina Cellular and Molecular Biology of Breast Cancer Plenum Press New York 479
92. C Redman 1998 Inhibitory effect of selenomethionine on the growth of three selected human tumor cell lines Cancer Lett. 125 1-2 103 110
93. L Kiremidjian-Schumacher G Stotzky 1987 Selenium and immune responses Environ Res. 42 2 277 303
94. T Shimada 1997 Inhibition of human cytochrome p450-catalyzed oxidations of xenobiotics and procarcinogens by synthetic organoselenium compounds Cancer Res. 57 21 4757 4764
95. HJ Thompson 1994 Comparison of the effects of an organic and an inorganic form of selenium on a mammary carcinoma cell line Carcinogenesis. 15 2 183 186
96. C Ip 2000 In vitro and in vivo studies of methylseleninic acid: evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention Cancer Res. 60 11 2882 2886
97. C Ip Y Dong HE Ganther 2002 New concepts in selenium chemoprevention Cancer Metastasis Rev. 21 3-4 281 289
98. Y Dong 2002 Identification of molecular targets associated with selenium-induced growth inhibition in human breast cells using cDNA microarrays Cancer Res. 62 3 708 714
99. Y Dong 2003 Delineation of the molecular basis for selenium-induced growth arrest in human prostate cancer cells by oligonucleotide array Cancer Res. 63 1 52 59
100. YR Seo MR Kelley ML Smith 2002 Selenomethionine regulation of p53 by a ref1-dependent redox mechanism Proc Natl Acad Sci USA. 99 22 14548 14553
101. AV Gasparian 2002 Selenium compounds inhibit I kappa B kinase (IKK) and nuclear factor-kappa B (NF-kappa B) in prostate cancer cells Mol Cancer Ther. 1 12 1079 1087
102. RJ Shamberger DV Frost 1969 Possible protective effect of selenium against human cancer Can Med Assoc. J 100 14 682
103. RJ Shamberger CE Willis 1971 Selenium distribution and human cancer mortality CRC Crit Rev Clin Lab Sci. 2 2 211 221
104. D Medina DG Morrison 1988 Current ideas on selenium as a chemopreventive agent Pathol Immunopathol Res. 7 3 187 199
105. LC Clark 1996 Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA. 276 24 1957 1963
106. EA Klein 2003 SELECT: the selenium and vitamin E cancer prevention trial Urol Oncol. 21 1 59 65
107. P van't Veer 1990 Selenium in diet, blood, and toenails in relation to breast cancer: a case-control study Am J Epidemiol. 131 6 987 994
108. P van't Veer 1991 Combination of dietary factors in relation to breast-cancer occurrence Int J Cancer. 47 5 649 653
109. E Hietanen 1994 Diet and oxidative stress in breast, colon and prostate cancer patients: a case-control study Eur J Clin Nutr. 48 8 575 586
110. JL Groff SS Gropper 2000 Advanced Nutrition and Human Metabolsim Belmont. Wadsworth Thomson Learning CA
111. MP Longnecker 1993 A 1-y trial of the effect of high-selenium bread on selenium concentrations in blood and toenails Am J Clin Nutr. 57 3 408 413
112. P Knekt 1990 Serum selenium and subsequent risk of cancer among Finnish men and women J Natl Cancer Inst. 82 10 864 868
113. K Overvad 1991 Selenium in human mammary carcinogenesis: a case-cohort study Eur J Cancer. 27 7 900 902
114. WC Willett 1983 Prediagnostic serum selenium and risk of cancer Lancet. 2 8342 130 134
115. JF Dorgan 1998 Relationships of serum carotenoids, retinol, alpha-tocopherol, and selenium with breast cancer risk: results from a prospective study in Columbia, Missouri (United States) Cancer Causes Control. 9 1 89 97
116. RJ Coates 1988 Serum levels of selenium and retinol and the subsequent risk of cancer Am J Epidemiol. 128 3 515 523
117. J Ringstad 1988 Serum selenium concentration associated with risk of cancer J Clin Pathol. 41 4 454 457
118. KP McConnell 1980 The relationship of dietary selenium and breast cancer J Surg Oncol. 15 1 67 70
119. S Chaitchik 1988 The distribution of selenium in human blood samples of Israeli population - comparison between normal and breast cancer cases Biol Trace Elem Res. 15 205 212
120. GN Schrauzer 1985 Selenium in the blood of Japanese and American women with and without breast cancer and fibrocystic disease Jpn J Cancer Res. 76 5 374 377
121. P Ghadirian 2000 A case-control study of toenail selenium and cancer of the breast, colon, and prostate Cancer Detect Prev. 24 4 305 313
122. PA van Noord 1993 Selenium and the risk of postmenopausal breast cancer in the DOM cohort Breast Cancer Res Treat. 25 1 11 19
123. PA van den Brandt 1994 Toenail selenium levels and the risk of breast cancer Am J Epidemiol. 140 1 20 26
124. DJ Hunter 1990 A prospective study of selenium status and breast cancer risk JAMA. 264 9 1128 1131
125. P van't Veer 1996 Tissue antioxidants and postmenopausal breast cancer: the European Community Multicentre Study on Antioxidants, Myocardial Infarction, and Cancer of the Breast (EURAMIC) Cancer Epidemiol Biomarkers Prev. 5 6 441 447
126. S Mannisto 2000 Toenail selenium and breast cancer-a case-control study in Finland Eur J Clin Nutr. 54 2 98 103
127. JJ Strain 1997 Thyroid hormones and selenium status in breast cancer Nutr Cancer. 27 1 48 52
128. YR Seo C Sweeney ML Smith 2002 Selenomethionine induction of DNA repair response in human fibroblasts Oncogene. 21 23 3663 3669
129. DP Lane 1992 Cancer. p53, guardian of the genome Nature. 358 6381 15 16
130. MB Kastan 1991 Participation of p53 protein in the cellular response to DNA damage Cancer Res. 51 23 Pt 1 6304 6311
131. MB Kastan 1992 A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia Cell. 71 4 587 597
132. Kowalska E, Narod SA, Huzarski T, et al. (2004) Increased rates of chromosome breakage in BRCA1 carriers are normalised by oral selenium supplementation. Cancer Epidemiol Biomarkers Prev
133. GN Schrauzer 2001 Nutritional selenium supplements: product types, quality, and safety J Am Coll Nutr. 20 1 1 4
134. C Ip DJ Lisk 1994 Bioactivity of selenium from Brazil nut for cancer prevention and selenoenzyme maintenance Nutr Cancer. 21 3 203 212
135. J Lu 1995 Dissociation of the genotoxic and growth inhibitory effects of selenium Biochem Pharmacol. 50 2 213 219
136. BH Patterson OA Levander 1997 Naturally occurring selenium compounds in cancer chemoprevention trials: a workshop summary Cancer Epidemiol Biomarkers Prev. 6 1 63 69
137. MS Stewart 1999 Selenium compounds have disparate abilities to impose oxidative stress and induce apoptosis Free Radic Biol Med. 26 1-2 42 48
138. HL Bradlow 1999 Phytochemicals as modulators of cancer risk Adv Exp Med Biol. 472 207 221
139. TM LaVallee 2002 2-methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors alpha and beta Cancer Res. 62 13 3691 3697
140. I Chen S Safe L Bjeldanes 1996 Indole-3-carbinol and diindolylmethane as aryl hydrocarbon (Ah) receptor agonists and antagonists in T47D human breast cancer cells Biochem Pharmacol. 51 8 1069 1076
141. J Schneider 1984 Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cancer cells J Biol Chem. 259 8 4840 4845
142. NT Telang 1992 Induction by estrogen metabolite 16 alpha-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells J Natl Cancer Inst. 84 8 634 638
143. HL Bradlow 1996 2-hydroxyestrone: the 'good' estrogen J Endocrinol. 150(Suppl) S259 S265
144. JH Fowke 2003 Urinary estrogen metabolites and breast cancer: differential pattern of risk found with pre- versus post-treatment collection Steroids. 68 1 65 72
145. GH Ho 1998 Urinary 2/16 alpha-hydroxyestrone ratio: correlation with serum insulin-like growth factor binding protein-3 and a potential biomarker of breast cancer risk Ann Acad Med Singapore. 27 2 294 299
146. GC Kabat 1997 Urinary estrogen metabolites and breast cancer: a case-control study Cancer Epidemiol Biomarkers Prev. 6 7 505 509
147. P Muti 2000 Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16alpha-hydroxyestrone ratio in premenopausal and postmenopausal women Epidemiology. 11 6 635 640
148. EN Meilahn 1998 Do urinary oestrogen metabolites predict breast cancer? Guernsey III cohort follow-up Br J Cancer. 78 9 1250 1255
149. JA Cauley 2000 Estrogen metabolites and breast cancer: a prospective study Era of Hope Department of Defense Breast Cancer Research Program Meeting Atlanta, GA
150. J Schneider 1982 Abnormal oxidative metabolism of estradiol in women with breast cancer Proc Natl Acad Sci USA. 79 9 3047 3051
151. HL Bradlow 1986 16 alpha-hydroxylation of estradiol: a possible risk marker for breast cancer Ann NY Acad Sci. 464 138 151
152. I Persson 1985 The risk of endometrial and breast cancer after estrogen treatment A review of epidemiological studies. Acta Obstet Gynecol Scand Suppl. 130 59 66
153. MP Osborne 1988 Omega-3 fatty acids: modulation of estrogen metabolism and potential for breast cancer prevention Cancer Invest. 8 629 631
154. CA Bradfield LF Bjeldanes 1987 Structure-activity relationships of dietary indoles: a proposed mechanism of action as modifiers of xenobiotic metabolism J Toxicol Environ Health. 21 3 311 323
155. LF Bjeldanes 1991 Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo: comparisons with 2,3,7,8-tetrachlorodibenzo-p-dioxin Proc Natl Acad Sci USA. 88 21 9543 9547
156. EL Cavalieri 1997 Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators Proc Natl Acad Sci USA. 94 20 10937 10942
157. F Yuan 1999 Anti-estrogenic activities of indole-3-carbinol in cervical cells: implication for prevention of cervical cancer Anticancer Res. 19 3A 1673 1680
158. Q Meng 2000 Suppression of breast cancer invasion and migration by indole-3-carbinol: associated with up-regulation of BRCA1 and E-cadherin/catenin complexes J Mol Med. 78 3 155 165
159. Q Meng 2000 Indole-3-carbinol is a negative regulator of estrogen receptor-alpha signaling in human tumor cells J Nutr. 130 12 2927 2931
160. S Fan 1999 BRCA1 inhibition of estrogen receptor signaling in transfected cells Science. 284 5418 1354 1356
161. Q Meng 2000 Inhibitory effects of Indole-3-carbinol on invasion and migration in human breast cancer cells Breast Cancer Res Treat. 63 2 147 152
162. TH Carter 2002 Diindolylmethane alters gene expression in human keratinocytes in vitro J Nutr. 132 11 3314 3324
163. EM Rosen 2003 BRCA1 gene in breast cancer J Cell Physiol. 196 1 19 41
164. NT Telang 1997 Inhibition of proliferation and modulation of estradiol metabolism: novel mechanisms for breast cancer prevention by the phytochemical indole-3-carbinol Proc Soc Exp Biol Med. 216 2 246 252
165. CM Cover 1998 Indole-3-carbinol inhibits the expression of cyclin-dependent kinase-6 and induces a G1 cell cycle arrest of human breast cancer cells independent of estrogen receptor signaling J Biol Chem. 273 7 3838 3847
166. CY Zhu S Loft 2003 Effect of chemopreventive compounds from Brassica vegetables on NAD(P)H:quinone reductase and induction of DNA strand breaks in murine hepa1c1c7 cells Food Chem Toxicol. 41 4 455 462
167. KJ Auborn 2003 Indole-3-carbinol is a negative regulator of estrogen J Nutr. 133 7Suppl 2470S 2475S
168. A McDougal 2001 Methyl-substituted diindolylmethanes as inhibitors of estrogen-induced growth of T47D cells and mammary tumors in rats Breast Cancer Res Treat. 66 2 147 157
169. HT Le 2003 Plant-derived 3,3′-diindolylmethane is a strong androgen antagonish in human prostate cancer cells J Biol Chem. 278 23 21136 21145
170. CM Cover 1999 Indole-3-carbinol and tamoxifen cooperate to arrest the cell cycle of MCF-7 human breast cancer cells Cancer Res. 59 6 1244 1251
171. NIH Chemoprevention Branch (2000) Safety study of diindolylmethane (Bio-Response DIM) versus Indole-3-carbionol in rats (on file). Boulder, co: BioResponse, LLC
172. WD Loub LW Wattenberg DW Davis 1975 Aryl hydrocarbon hydroxylase induction in rat tissues by naturally occurring indoles of cruciferous plants J Natl Cancer Inst. 54 4 985 988
173. Arneson DW, et al. (1999) Presence of 3,3′-diindolylmethane in human plasma after oral administration of Indole-3-carbinol. In: Proceedings of the American Association for Cancer Research
174. CA De Kruif 1991 Structure elucidation of acid reaction products of indole-3-carbinol: detection in vivo and enzyme induction in vitro Chem Biol Interact. 80 3 303 315
175. P Di Mascio S Kaiser H Sies 1989 Lycopene as the most efficient biological carotenoid singlet oxygen quencher Arch Biochem Biophys. 274 2 532 538
176. S Agarwal AV Rao 2000 Tomato lycopene and its role in human health and chronic diseases CMAJ. 163 6 739 744
177. E Giovannucci 1999 Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologic literature J Natl Cancer Inst. 91 4 317 331
178. DS Michaud 1998 Associations of plasma carotenoid concentrations and dietary intake of specific carotenoids in samples of two prospective cohort studies using a new carotenoid database Cancer Epidemiol Biomarkers Prev. 7 4 283 290
179. VL Freeman 2000 Prostatic levels of tocopherols, carotenoids, and retinol in relation to plasma levels and self-reported usual dietary intake Am J Epidemiol. 151 2 109 118
180. J Levy 1995 Lycopene is a more potent inhibitor of human cancer cell proliferation than either alpha-carotene or beta-carotene Nutr Cancer. 24 3 257 266
181. H Nagasawa 1995 Effects of lycopene on spontaneous mammary tumour development in SHN virgin mice Anticancer Res. 15 4 1173 1178
182. Y Sharoni 1997 Effects of lycopene-enriched tomato oleoresin on 7,12-dimethyl-benz[a]anthracene-induced rat mammary tumors Cancer Detect Prev. 21 2 118 123
183. W. Stahl 1992 cis-trans isomers of lycopene and β-carotene in human serum and tissues Arch Biochem Biophys. 294 1 173 177
184. LA Kaplan JM Lau EA Stein 1990 Carotenoid composition, concentrations, and relationships in various human organs Clin Physiol Biochem. 8 1 1 10
185. HH Schmitz 1991 Concentrations of selected carotenoids and vitamin A in human liver, kidney and lung tissue J Nutr. 121 10 1613 1621
186. DW Nierenberg SL Nann 1992 A method for determining concentrations of retinol, tocopherol, and five carotenoids in human plasma and tissue samples Am J Clin Nutr. 56 2 417 426
187. AV Rao S Agarwal 1999 Role of lycopene as antioxidant carotenoid in the prevention of chronic diseases: a review Nutr Res. 19 305 323
188. ML Nguyen SJ Schwartz 1999 Lycopene: chemistry, biology, and implications for human health and disease Food Technol 53 35 51
189. W Stahl H Sies 1992 Uptake of lycopene and its geometrical isomers is greater from heat-processed than from unprocessed tomato juice in humans J Nutr. 122 11 2161 2166
190. C Gartner W Stahl H Sies 1997 Lycopene is more bioavailable from tomato paste than from fresh tomatoes Am J Clin Nutr. 66 1 116 122
191. P Riso 1999 Does tomato consumption effectively increase the resistance of lymphocyte DNA to oxidative damage? Am J Clin Nutr. 69 4 712 718
192. S Agarwal AV Rao 1998 Tomato lycopene and low density lipoprotein oxidation: a human dietary intervention study Lipids. 33 10 981 984
193. AV Rao S Agarwal 1998 Bioavailability and in vivo antioxidant properties of lycopene from tomato products and their possible role in the prevention of cancer Nutr Cancer. 31 3 199 203
194. BL Pool-Zobel 1997 Consumption of vegetables reduces genetic damage in humans: first results of a human intervention trial with carotenoid-rich foods Carcinogenesis. 18 9 1847 1850
195. A Nahum 2001 Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes Oncogene. 20 26 3428 3436
196. MD Planas-Silva RA Weinberg 1997 Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution Mol Cell Biol. 17 7 4059 4069
197. CK Watts 1994 Antiestrogen regulation of cell cycle progression and cyclin D1 gene expression in MCF-7 human breast cancer cells Breast Cancer Res Treat. 31 1 95 105
198. GD Stoner H Mukhtar 1995 Polyphenols as cancer chemopreventive agents J Cell Biochem Suppl. 22 169 180
199. TK Basu NJ Temple ML Garg 1999 Potential role of antioxidant vitamins TK Basu Antioxidants in Human Health and Disease CABI Publishing Wallingford 15 26
200. E Kaegi 1998 Unconventional therapies for cancer: 2 Green tea. The task force on alternative therapies of the canadian breast cancer research initiative. CMAJ. 158 8 1033 1035
201. KT Kavanagh 2001 Green tea extracts decrease carcinogen-induced mammary tumor burden in rats and rate of breast cancer cell proliferation in culture J Cell Biochem. 82 3 387 398
202. H Tanaka 1997 Post-initiation inhibitory effects of green tea catechins on 7,12-dimethylbenz[a]anthracene-induced mammary gland carcinogenesis in female Sprague-Dawley rats Cancer Lett. 116 1 47 52
203. M Hirose 1994 Inhibition of mammary gland carcinogenesis by green tea catechins and other naturally occurring antioxidants in female Sprague-Dawley rats pretreated with 7,12-dimethylbenz[alpha]anthracene Cancer Lett. 83 1-2 149 156
204. CS Yang ZY Wang 1993 Tea and cancer J Natl Cancer Inst. 85 13 1038 1049
205. DL McKay JB Blumberg 2002 The role of tea in human health: an update J Am Coll Nutr. 21 1 1 13
206. RA Goldbohm 1996 Consumption of black tea and cancer risk: a prospective cohort study J Natl Cancer Inst. 88 2 93 100
207. W Zheng 1996 Tea consumption and cancer incidence in a prospective cohort study of postmenopausal women Am J Epidemiol. 144 2 175 182
208. KB Michels 2002 Coffee, tea, and caffeine consumption and breast cancer incidence in a cohort of Swedish women Ann Epidemiol. 12 1 21 26
209. TJ Key 1999 Soya foods and breast cancer risk: a prospective study in Hiroshima and Nagasaki, Japan Br J Cancer. 81 7 1248 1256
210. J Nagano 2001 A prospective study of green tea consumption and cancer incidence, Hiroshima and Nagasaki (Japan) Cancer Causes Control. 12 6 501 508
211. K Nakachi 1998 Influence of drinking green tea on breast cancer malignancy among Japanese patients Jpn J Cancer Res. 89 3 254 261
212. M Inoue 2001 Regular consumption of green tea and the risk of breast cancer recurrence: follow-up study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC), Japan Cancer Lett. 167 2 175 182
213. AH Wu 2003 Green tea and risk of breast cancer in Asian Americans Int J Cancer. 106 4 574 579
214. SD Hursting 2000 Nutritional modulation of the carcinogenesis process: targets and examples JBN Mason G Nitenbug cancer & Nutrition: Prevention and Treatment Vevey Karger AG 1 22
215. PM, SS Greenwald 1999 Antioxidants and the prevention of cancer TK Basu Antioxidants in Human Health and Disease CABI Publishing Wallingford 217 234
216. RF Anderson 2001 Green tea catechins partially protect DNA from OH radical-induced strand breaks and base damage through fast chemical repair of DNA radicals. Carcinogenesis. 22 8 1189 1193
217. M Masuda M Suzui IB Weinstein 2001 Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines Clin Cancer Res. 7 12 4220 4229
218. S Pianetti 2002 Green tea polyphenol epigallocatechin-3 gallate inhibits Her-2/neu signaling, proliferation, and transformed phenotype of breast cancer cells Cancer Res 62 3 652 655
219. YC Liang 1997 Suppression of extracellular signals and cell proliferation through EGF receptor binding by (-)-epigallocatechin gallate in human A431 epidermoid carcinoma cells J Cell Biochem. 67 1 55 65
220. CL Arteaga 2002 Overview of epidermal growth factor receptor biology and its role as a therapeutic target in human neoplasia Semin Oncol. 29 5 Suppl 14 3 9
221. S Nicholson 1989 Expression of epidermal growth factor receptors associated with lack of response to endocrine therapy in recurrent breast cancer Lancet. 1 8631 182 185
222. JR Sainsbury 1987 Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer Lancet. 1 8547 1398 1402
223. D Yu MC Hung 2000 Overexpression of ErbB2 in cancer and ErbB2-targeting strategies Oncogene. 19 53 6115 6121
224. J Kaput RL Rodriguez 2004 Nutritional genomics: the next frontier in the postgenomic era Physiol Genomics. 16 2 166 177
225. P Trayhurn 2003 Nutritional genomics - "Nutrigenomics" Br J Nutr. 89 1 1 2
226. B van Ommen R Stierum 2002 Nutrigenomics: exploiting systems biology in the nutrition and health arena Curr Opin Biotechnol. 13 5 517 521
227. A Schatzkin 1997 Using and interpreting surrogate end-points in cancer research P Toniolo Application of Biomarkers in Cancer Epidemiology International Agency for Research on Cancer Lyon
228. Panel on Dietary Antioxidants and Related Compounds, FaNB Institute of Medicine (2000) Selenium. In: Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids, Washington, DC: National Academy Press, pp. 284-32
229. GF Combs Jr 2001 Impact of selenium and cancer-prevention findings on the nutrition-health paradigm Nutr Cancer. 40 1 6 11
230. GF Combs Jr 2001 Selenium in global food systems Br J Nutr. 85 5 517 547
231. G Yang R Zhou 1994 Further observations on the human maximum safe dietary selenium intake in a seleniferous area of China J Trace Elem Electrolytes Health Dis. 8 3-4 159 165
232. Institute of Medicine, FaNB (2000) Dietary Reference Intakes: Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington, DC: National Academy Press
233. MA. Zeligs AS. Connelly 2000 All About DIM Avery New York
234. Zeligs MA, Zeligs ET, Albert D (1999) "An open label study of BioResponse-DIM for promotion of weight loss during a modified carbohydrate diet". Data on file. Boulder, co:Bioresponse LIC
235. AV Rao H Shen 2002 Effect of low dose lycopene intake on lycopene bioavailability and oxidative stress Nutr Res. 22 1125 1131
236. L Chen 2001 Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention J Natl Cancer Inst. 93 24 1872 1879
237. H Fujiki 2002 Green tea: cancer preventive beverage and/or drug Cancer Lett. 188 1-2 9 13
238. K Imai K Suga K Nakachi 1997 Cancer-preventive effects of drinking green tea among a Japanese population Prev Med. 26 6 769 775
239. K Nakachi 2000 Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention Biofactors. 13 1-4 49 54
240. E Riboli 2000 The european prospective invetgation into cancer and nutrition: perspectives for cancer prevention JBN Mason G Nitenburg Cancer & Nutrition: Prevention and Treatment Vevey Karger. AG 117 133